Feedback (LON:FDBK) Insider Tom Oakley Acquires 60,904 Shares
by Sarita Garza · The Markets DailyFeedback plc (LON:FDBK – Get Free Report) insider Tom Oakley purchased 60,904 shares of Feedback stock in a transaction that occurred on Tuesday, December 23rd. The shares were bought at an average cost of GBX 8 per share, for a total transaction of £4,872.32.
Feedback Trading Up 3.8%
LON:FDBK traded up GBX 0.30 during trading hours on Tuesday, hitting GBX 8.30. The stock had a trading volume of 325,398 shares, compared to its average volume of 94,928. The company has a market cap of £3.64 million, a PE ratio of -0.33 and a beta of 0.77. The business has a 50 day simple moving average of GBX 8.54 and a two-hundred day simple moving average of GBX 11.58. Feedback plc has a 1-year low of GBX 7.50 and a 1-year high of GBX 21.40.
About Feedback
Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.
Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.
By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.
Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.
Featured Articles
- Five stocks we like better than Feedback
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Elon Warns “America Is Broke”. Trump’s Plan Inside.
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why